Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GSK

GSK (GSK)

GSK plc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GSK

<< Previous 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 Next >>

Date	Time	Source	Headline	Symbol	Company
05/14/2018	5:32PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NYSE:GSK	GSK plc
05/11/2018	11:49AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/11/2018	9:15AM	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NYSE:GSK	GSK plc
05/11/2018	9:04AM	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NYSE:GSK	GSK plc
05/10/2018	12:51PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/10/2018	9:41AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NYSE:GSK	GSK plc
05/10/2018	9:06AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/09/2018	1:12PM	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	NYSE:GSK	GSK plc
05/09/2018	8:07AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/09/2018	7:47AM	Dow Jones News	GlaxoSmithKline CFO to Retire in May 2019	NYSE:GSK	GSK plc
05/09/2018	7:30AM	GlobeNewswire Inc.	Adaptimmune Reports First Quarter 2018 Financial Results and Business Update	NYSE:GSK	GSK plc
05/03/2018	2:35PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/03/2018	2:14PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
05/01/2018	1:02PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/27/2018	8:23AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/26/2018	12:55PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/25/2018	4:20PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/25/2018	9:32AM	Dow Jones News	GlaxoSmithKline 1Q Earnings Impacted by FX Effects -- Earnings Review	NYSE:GSK	GSK plc
04/25/2018	8:04AM	Dow Jones News	GlaxoSmithKline 1Q Profit and Revenue Falls, Backs Guidance	NYSE:GSK	GSK plc
04/25/2018	8:00AM	GlobeNewswire Inc.	Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018	NYSE:GSK	GSK plc
04/24/2018	1:52PM	Dow Jones News	GlaxoSmithKline's Trelegy Ellipta Gets Expanded Indication From FDA	NYSE:GSK	GSK plc
04/24/2018	1:38PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/24/2018	12:55PM	Business Wire	Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD	NYSE:GSK	GSK plc
04/20/2018	11:00AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/20/2018	10:50AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/19/2018	7:27AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/19/2018	7:00AM	GlobeNewswire Inc.	NeuroMetrix Reports Q1 2018 Financial Results	NYSE:GSK	GSK plc
04/18/2018	5:00PM	Business Wire	Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD	NYSE:GSK	GSK plc
04/17/2018	10:06AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
04/17/2018	9:48AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc

Showing the most relevant articles for your search:NYSE:GSK

<< Previous 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 Next >>

Seafarer Exploration (PK)

Asia Broadband (PK)

Moon Equity (PK)

Maxeon Solar Technologies

Code Green Apparel (PK)

FuelCell Energy

Ronn Motor (PK)

Progressive Care (QB)

TPT Global Tech (PK)

Impact Fusion (PK)

Virexit Technologies (PK)

Rennova Health (PK)

Lightwave Logic

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions